ArticleCancer medicine2018
How great is current curative expenditure and catastrophic health expenditure among patients with cancer in China? A research based on "System of Health Account 2011".
Article in Cancer medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 6 syntheses or guidelines pooled it, 43 citations in OpenAlex.
- Effects of health insurance on economic burden and health service utilization among people with noncommunicable diseases in low- and middle-income countries: a systematic review.BMC public health · 2026Pooled it
- Magnitude of catastrophic health expenditure and its determinants among cancer patients in low and middle-income countries: a systematic review and meta-analysis.BMC health services research · 2025Pooled it
- The financial toxicity of cancer: unveiling global burden and risk factors - a systematic review and meta-analysis.BMJ global health · 2025Pooled it
- Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Pooled it
- Incidence of Catastrophic Health Expenditure and Its Determinants in Cancer Patients: A Systematic Review and Meta-analysis.Applied health economics and health policy · 2021Pooled it
- Economic status and catastrophic health expenditures in China in the last decade of health reform: a systematic review and meta-analysis.BMC health services research · 2021Pooled it
- Pathways to Care, Out- of- Pocket Expenditure, and Associated Factors Among Breast Cancer Patients in Kerala, India: A Hospital-Based Cross- Sectional Study.Asian Pacific journal of cancer prevention : APJCP · 2026Article
- Potential profile analysis of financial toxicity and its related factors among lung cancer patients.BMC cancer · 2025Article
- Catastrophic health expenditure and distress financing of breast cancer treatment in India: evidence from a longitudinal cohort study.International journal for equity in health · 2024Article
- Evaluation of Financial Interventions in Breast Cancer Care Worldwide: A Systematic Review.Plastic and reconstructive surgery. Global open · 2024Article
- Out-of-pocket payment and financial risk protection for breast cancer treatment: a prospective study from India.The Lancet regional health. Southeast Asia · 2024Article
- Catastrophic health expenditures in hospitalized patients with delta variant of COVID-19: A cross-sectional study.Health promotion perspectives · 2023Article
- Financial toxicity in female patients with breast cancer: a national cross-sectional study in China.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- A systematic review of financial toxicity among cancer patients in China.Asia-Pacific journal of oncology nursing · 2022Review
- Differences in medical costs among urban lung cancer patients with different health insurance schemes: a retrospective study.BMC health services research · 2022Article
- The out-of-pocket cost of breast cancer care at a public tertiary care hospital in Nigeria: an exploratory analysis.The Pan African medical journal · 2022Article
- Private Healthcare Expenditure in China: A Regional Comparative Analysis.Healthcare (Basel, Switzerland) · 2021Article
- Case study of the beneficiary group distribution of curative care expenditure based on SHA 2011 in Xinjiang autonomous region, China.BMJ open · 2021Article
- Incidence of household catastrophic and impoverishing health expenditures among patients with Breast Cancer in Iran.BMC health services research · 2021Article
- Factors associated with child delivery expenditure during the transition to the national implementation of the two-child policy in China.Health and quality of life outcomes · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, the incidence and mortality of cancer have witnessed a dramatic increase. Cancer has already caused severe economic burdens on society, especially in developing countries and has become a major public health concern. This study evaluates the medical economic burden, including total current curative expenditure (CCE) and catastrophic health expenditure (CHE) on cancer in Liaoning Province, China. A total of 252 medical institutions were investigated with multistage stratified cluster random sampling. We established a standardized database of 3 532 517 samples. "System of Health Account 2011", a new internationally recognized accounting system, was established to analyze the CCE on six most common cancers. CHE were estimated from the extracted 1344 patients with cancer, which performed a cross-sectional study. The association of individual and contextual factors with CHE was evaluated using logistic regression models. CCE for all the patients with the six types of cancer was 2801.38 million CNY in Liaoning Province, the highest of which was lung cancer. The incidence of CHE was 42.78%, while the threshold was 40%. The average and relative distance were 10.41% and 24.32%, respectively. Influencing factors were length of stay, type of health insurance, location of household, etc. Our findings highlight the need to address medical economic burden in the cancer population. Households with the cancer are more likely to incur CHE. Financial intervention to prevent it should target on poor households. We provide suggestions in aspects of health insurance and health service management to reduce CHE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.